Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non-small cell lung cancer: Results from a randomized trial

Lee, BJM; Mynard, N; Nasar, A; Villena-Vargas, J; Chow, O; Harrison, S; Stiles, B; Port, J; Altorki, N

Altorki, N (通讯作者),Dept Cardiothorac Surg, 525 E 68th St,M 404, New York, NY 10065 USA.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2023; 165 (1): 327